Skip to content

Ventriculostomies in SAH: ICP Open or Not?

Ventriculostomies in SAH: ICP Open or Not?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00787020
Acronym
VISION
Enrollment
37
Registered
2008-11-07
Start date
2008-11-30
Completion date
2010-02-28
Last updated
2015-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subarachnoid Hemorrhage

Keywords

Cerebrospinal Fluid, Ventriculostomy, Subarachnoid hemorrhage, vasospasm, Human Subjects

Brief summary

The purpose of this study is explore how cerebrospinal fluid (CSF) drainage impacts outcomes for patients diagnosed with subarachnoid hemorrhage (SAH). This is a non-randomized observational study of two physician-prescribed approaches to managing intracranial pressure monitoring and CSF drainage for SAH patients. The study will enroll only those patients who have intracranial pressure (ICP) monitoring in situ. Because this is an observational study, there are no physical risks to the patient, the only risk is loss of confidentiality.

Detailed description

There are no interventions specific to this observational study. The nurses and physicians who care for subjects in the study are already competent in the care and management of patients with subarachnoid hemorrhage (SAH) and intracranial pressure (ICP) monitoring as a requirement of their current employment at Duke University. Patients with confirmed diagnosis of subarachnoid hemorrhage requiring ICP and CSF management will be admitted to the 16 bed Neurocritical Care Unit (NCCU) at Duke Hospital. After admission procedures and a baseline neurologic assessment are complete, the charge nurse or NCCU fellow will notify an investigator of subjects meeting inclusion criteria. The investigator or research coordinator for this project will complete a review preparatory to research (RPR) to ensure no exclusion criteria are present and once subject appropriateness has been confirmed patients and their families will be introduced to the investigator for the purpose of obtaining informed consent. The subject's legally authorized representative (LAR) will be informed of the study's purpose, risks and benefits, and the rights of research subjects. Data will be collected that reflects the duration of the patient's hospitalization at Duke University through chart abstraction. The study period will be defined as admission to discharge. The attending physician has, and will continue to, determine the appropriateness of the duration of ICP monitoring, NCCU discharge criteria and hospital discharge criteria. Chart abstraction will be completed daily to obtain the ICP values and CSF volumes during that period of time for which the patient has a ventriculostomy.

Interventions

None listed

Sponsors

Duke University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of subarachnoid hemorrhage * Age 18 years or older * Ventriculostomy in situ

Exclusion criteria

* Prisoners * Glasgow coma score = 3

Design outcomes

Primary

MeasureTime frameDescription
Cerebral Artery Vasospasm14 daysCerebral artery vasospasm is defined as transcranial doppler mean velocity greater than 120 or angiographic vasospasm determined by cerebral angiogram.

Secondary

MeasureTime frameDescription
External Ventricular Drain (EVD) Complications14 DaysExternal ventricular drain complications are defined as ventriculitis, shunt dependency, ventricular catheter obstruction requiring manipulation, or removal by the patient.
Cerebrospinal Fluid (CSF) Output Per Day14 Days

Countries

United States

Participant flow

Participants by arm

ArmCount
Ventriculostomy Open
Subjects are treated with near continuous cerebrospinal fluid (CSF) diversion by position the stopcock in the open position and the intracranial pressure (ICP) is monitored each hour: CSF drains into an external ventricular drainage bag.
24
Ventriculostomy Monitored
Subjects are treated with intermittent cerebrospinal fluid (CSF) diversion. Intracranial pressure (ICP) is monitored and CSF is drained only when the ICP exceeds a threshold dictated by the attending physician.
13
Total37

Baseline characteristics

CharacteristicVentriculostomy MonitoredVentriculostomy OpenTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants4 Participants7 Participants
Age, Categorical
Between 18 and 65 years
10 Participants20 Participants30 Participants
Age, Continuous53.13 years
STANDARD_DEVIATION 11.13
55.92 years
STANDARD_DEVIATION 13.35
54.11 years
STANDARD_DEVIATION 11.85
Region of Enrollment
United States
13 participants24 participants37 participants
Sex: Female, Male
Female
9 Participants16 Participants25 Participants
Sex: Female, Male
Male
4 Participants8 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 240 / 13
serious
Total, serious adverse events
0 / 240 / 13

Outcome results

Primary

Cerebral Artery Vasospasm

Cerebral artery vasospasm is defined as transcranial doppler mean velocity greater than 120 or angiographic vasospasm determined by cerebral angiogram.

Time frame: 14 days

ArmMeasureValue (NUMBER)
Ventriculostomy OpenCerebral Artery Vasospasm16 Participants
Ventriculostomy MonitoredCerebral Artery Vasospasm7 Participants
Secondary

Cerebrospinal Fluid (CSF) Output Per Day

Time frame: 14 Days

ArmMeasureValue (MEAN)
Ventriculostomy OpenCerebrospinal Fluid (CSF) Output Per Day134 Milliliter
Ventriculostomy MonitoredCerebrospinal Fluid (CSF) Output Per Day135 Milliliter
Secondary

External Ventricular Drain (EVD) Complications

External ventricular drain complications are defined as ventriculitis, shunt dependency, ventricular catheter obstruction requiring manipulation, or removal by the patient.

Time frame: 14 Days

ArmMeasureValue (NUMBER)
Ventriculostomy OpenExternal Ventricular Drain (EVD) Complications14 Participants
Ventriculostomy MonitoredExternal Ventricular Drain (EVD) Complications4 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026